OMAHA, Neb. & PHOENIX--(BUSINESS WIRE)--CCT Research announced today plans to operate as a study site for, and begin enrolling participants into, the global Phase 3 RENOIR (RSV vaccine Efficacy study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results